tbuckley/cabot-search huggingface dataset:
Emergency Operations for General Practitioners on Land and Sea. An Illustrated Manual of Procedure and Technique.
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Bovine Somatotropin
Authors: James M. Gilchrist
Journal: JAMA (1991)

<h3>To the Editor.—</h3> I read Dr Grossman's<sup>1</sup>editorial with extreme consternation. The medical aspects of bovine growth hormone (bST) are an appropriate topic for consideration in a medical journal, but your editorial far exceeded that issue in its attempt to justify the use of bST in the American dairy industry. One must ask who is to benefit from the use of this bioengineering at a time when dairy farmers are disappearing in record numbers due to falling demand, increasing costs, and rising pressure for land development. The use of bST will certainly not benefit the farmer, as your editorial so blithely notes, nor will it benefit the consumer, whose potential savings from increased production (which would come from the profits of the failing farmers) will probably never appear because of the increased costs of caring for dairy cattle receiving bST and the cost of the hormone itself. The cattle
BOOK REVIEWS
Journal: British Journal of Dermatology (1967)

British Journal of DermatologyVolume 79, Issue 8-9 p. 504-504 BOOK REVIEWS First published: August 1967 https://doi.org/10.1111/j.1365-2133.1967.tb11543.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract Book review in this article Scleroderma. M. A. Sackner (1966). Roxburgh's Common Skin Diseases. P. Borrie (1967). An Introduction to Dermatology. G. H. Percival (1967). Encyclopedic Medico-Chirurgicale. Special Volume No. 52, Issue No. 27. Nomenclature of Fungi Pathogenic to Man and Animals. (1967) M.R.C Memorandum No. 23 (3rd Ed). Volume79, Issue8-9August 1967Pages 504-504 RelatedInformation
Paraplegia after elective repair of an infrarenal aortic aneurysm
Authors: I. H Mallick, S. Kumar, A. Samy
Journal: Journal of the Royal Society of Medicine (2003)

Risk factors for development of KVE remain unclear.A report of two cases in patients with atopic dermatitis treated with topical tacrolimus suggests that downregulation of cutaneous cell-mediated immunity can increase the risk in susceptible individuals. 5 A case report of KVE after sun exposure points to non-ionizing radiation as another possible trigger. 6 In the present case, the direct cause of the disseminated herpes simplex eruption is uncertain.Clearly, the patient was already immunosuppressed by her chronic lymphocytic leukaemia and by the various immunomodulatory treatments for mycosis fungoides; therefore, it is quite possible that the temporal relation between initiation of total skin radiotherapy and occurrence of KVE arose solely by chance.Alternatively, the radiotherapy may have further suppressed cutaneous cellmediated immunity and thus put the patient at risk of herpes infection.Only one other group has documented KVE after total skin electron therapy.In this report, a woman of 39 with plaque stage mycosis fungoides developed KVE after receiving 4600 cGy to all skin surfaces. 3From serial samples of peripheral blood, the investigators detected a transient depression of natural killer cell activity that coincided with the start of radiotherapy and may have contributed to the development of KVE.Our case report illustrates that KVE can occur even after small doses of external radiation.Radiation oncologists, dermatologists, and general practitioners should be aware that a vesicular eruption during the course of total skin radiotherapy may signify a life-threatening condition that requires immediate diagnosis and intravenous antiviral therapy.In view of the rarity of this complication, we do not advise routine antiviral prophylaxis during total skin radiotherapy.
Yersinia arthritis.
Authors: J T Scott, N S Mair
Journal: BMJ (1979)

asymptomatic.4All raw pork handled by the patient was of local origin.Y enterocolitica has not been reported in British pigs.The only neurological complication previously recorded was a case of Guillain-Barre syndrome.5Neuralgic amyotrophy was recognised during the last war.It is of unknown aetiology but may follow dysentery or Reiter's syndrome.Severe pain in the shoulder girdle is followed by rapid wasting.Sensory loss is minimal and recovery usually good.Extensor plantars may occur.When enteritis and abdominal pain is followed by lower-limb polyarthritis, salmonellae, shigellae, and yersiria should be sought in the acute phase by culture and serology.Underestimation of the true prevalernce is likely.
Erratum for the Research Article: “Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer” by H. Luo, Q. Zhao, W. Wei, L. Zheng, S. Yi, G. Li, W. Wang, H. Sheng, H. Pu, H. Mo, Z. Zuo, Z. Liu, C. Li, C. Xie, Z. Zeng, W. Li, X. Hao, Y. Liu, S. Cao, W. Liu, S. Gibson, K. Zhang, G. Xu, R.-h. Xu
Journal: Science Translational Medicine (2020)
Errata
Authors: Mitchell Henry, W Wall, J Elkington, T Newham, M Coulcher, J Falconer, J Pellegrin, B Marsack, James Henry, Lakin Halsted, Warwickshire Atherstone, Edinburgb Gylles Crooke, James William, India Williams, Henry Potter, Bristol Coltliurst, G Hetling
Journal: BMJ (1848)

in this terrible disease, I beg to relate a case which a few years ago occurred in my practice.Case.-Jobn Springer, a carpenter, about 50 years of age, of intemperate babits, was attacked with symptoms of laryngitis, but not at first of a severe cbaracter.He was not a subject for general bleeding.Leeches and blisters were applied, and calomel and antimony administered.On the evening of the second day a great aggravation of symnptoms occutrred, threatening speedy suffocation.I sent hastily for my neighbour, Mr. Smith, the surgeon, and in a few minutes I placed a tube in an opening made through the crico-thyroid membrane, apprehending every moment the patient would breath his last, before he could be got out of bed within our reach and the operation performed.The result was most favourable.Immediate relief followed thie operation and the disease rapidly subsided under the constitutional effects of mercury.I saw this man in the street a few days ago; he has been perfectly well ever since.I am, Sir, your obedient servant, N.
AMA Expands Approach to Residency Forum
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
CARE IN SIGNING CERTIFICATES.
Journal: JAMA (1900)

A little care now and then will save a doctor some embarrassing mistakes. Not very long ago the newspapers contained the story of a physician who, from carelessness in affixing his signature on birth certificates, nearly ruined his reputation by giving himself as parent of those he had assisted into the world. He simply wrote his name in the wrong place on a few forms, and obtained for himself a regular Mormon reputation. Another doctor carelessly certified the cause of death on a certificate as "old age," giving the age of the patient as the duration of the disease—81 years. The certificate therefore declared the man born old and suffering all his life from senility which finally carried him off. Such little errors are comparatively unimportant, and easily corrected as a rule, but they may make one who commits them temporarily uncomfortable. As in signing petitions, men too often put
Effects of Estrogen-Only Treatment in Postmenopausal Women—Reply
Authors: Garnet L. Anderson
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Response
Authors: J. M. KOLESAR, H. A. BURRIS, J. G. KUHN
Journal: JNCI Journal of the National Cancer Institute (1995)

larger study, with proper controls and analysis by age, sex, tumor stage, and environmental risk factors in addition to genotype, may be more informative.Such studies are under way.Also, one cannot rule out the possibility that differences in allele distribution may be associated with syndromic forms of colon cancer, such as Gardner's syndrome.Finally, it is worth noting that Eickelmann et al. ( 6) have described the same polymorphism in three individuals with kidney cancer; they also described a quick and reliable PCR restriction fragment length polymorphism assay for its detection.
Surgery
Authors: Arthur E. Baue
Journal: JAMA (1978)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Aluminium containers.
Authors: S Shaw
Journal: BMJ (1972)

18 3 (16-6) 2 (11 1) Cirrhosis Posthepatitis .17 6(35 2) 4 (23 5) Cryptogenic .43 13 (30 2) 8 (18-6) Alcoholic 11 1 (9 9) 1 (9 9) Other Chronic Liver Diseases .. 15 1 (6 6) 1 (6 6)
Comments on Feldshers
Journal: JAMA (1972)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Quantitative nuclease protection assay (qNPA) for gene expression analysis on breast cancer core biopsies.
Authors: M. C. Evangelist, J. Krushkal, Y. Qu, A. Kulkarni, B. Kerns, B. Seligmann, J. C. Sachdev
Journal: Journal of Clinical Oncology (2011)

e21087 Background: qNPA employs in situ hybridization of detection probes to cross linked mRNA, making it ideal for formalin fixed paraffin embedded (FFPE) tissue. It has been shown to measure gene expression in archived lymphoid and lung cancer tissue. We assessed the feasibility of qNPA to measure differentially expressed genes in pretreatment FFPE core breast biopsies among pathologic responders (pR) and nonresponders (pNR) to preoperative chemotherapy. Methods: We included preoperative breast cancer patients treated at our institution from 2003-09 with FFPE core biopsies. mRNA expression of 170 genes, representing oncogenic pathways or associated with anthracycline and taxane response was measured by qNPA (HTG, Tucson, AZ). Data was normalized to 3 housekeeper genes and average of 3 biologic replicates reported. Seven genes below detection in > 50% samples were excluded. Expression values of 163 unique genes were analyzed for pR vs pNR with dChip software. Empirical FDR was estimated using 1,000 permutations of sample labels. Results: Treatment and Response: Sample failure: 6/57 (10%). pR vs pNR did not separate on hierarchical clustering. FLJ12650 and IGFBP2 showed lower expression in pR vs pNR with fold changes of 4.09 and 2.40, respectively (p < 0.01; median FDR: 1/163). FLJ12650 was significant (p < 0.01, median FDR: 0/163) when patients receiving anthracycline ± taxane were analyzed (groups 1-3) and group 1 trended to significance (p < 0.05). Conclusions: qNPA for limited available FFPE tissue from core biopsies is feasible with acceptable sample failure rates. Small sample size and number of analyzed genes limited definitive conclusion about informative genes in our study. Our FLJ12650 results, a gene coding for membrane Na+/K+ ATPase interacting protein, are consistent with previous findings of overexpression in pNR to anthracyclines + taxanes (Hess et al, JCO 2006, Vol 24; 4236) using fresh tissue. Future qNPA validation of predictive markers, identified by whole transcriptome analysis in a homogenous cohort may provide more definitive results. N = 57 N (%) Chemotherapy groups 1 AC + docetaxel 2 AC + paclitaxel 3 AC 4 Nonanthracycline 31 (54) 6 (10) 10 (18) 10 (18) Response pR pNR 11 (19) 46 (81)
THE TARSOPHALANGEAL REFLEX.
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Thrombocythemia, thrombocytosis
Authors: H. C. Hoagland
Journal: JAMA (1976)

IN MANY of the myeloproliferative syndromes, such as polycythemia vera, primary hemorrhagic thrombocythemia, chronic granulocytic leukemia, and agnogenic myeloid metaplasia, platelet counts may be in excess of 1,000,000/cu mm. This is especially true of primary hemorrhagic thrombocythemia and agnogenic myeloid metaplasia when the spleen has been removed.<sup>1</sup>Other conditions known to be associated with thrombocytosis, such as malignancy, iron deficiency anemia, and chronic inflammatory diseases (eg, rheumatoid arthritis or collagen disorders), are less likely to produce platelet counts in excess of 1 million. Even a patient who has had a splenectomy for other reasons will rarely have platelet counts above 1 million. Transient increases in platelets seen in the ten-day postoperative period do not appear to increase morbidity. In the myeloproliferative syndromes, platelet counts in excess of 1 million are frequently associated with thrombotic episodes and hemorrhagic manifestations. Thrombosis tends to involve the large vessels, such as the mesenteric
Methadone and Acetylmethadol Maintenance
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
WILLING ONE'S BODY
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Meso-2,3-Dimercaptosuccinic Acid: Chemical, Pharmacological And Toxicological Properties Of An Orally Effective Metal Chelating Agent
Authors: H. Aposhian
Journal: The Annual Review of Pharmacology and Toxicology (1990)

Due to the massive data sets available for drug candidates, modern drug discovery has advanced to the big data era. Central to this shift is the development of artificial intelligence approaches to implementing innovative modeling based on the dynamic, ...Read More